Anthropic disabled access to its frontier models Claude Fable 5 and Claude Mythos 5 on June 12 after the U.S. government issued an export‑control directive citing national security concerns. The order bars foreign nationals worldwide from using the systems, forcing Anthropic to turn both models off for every customer while it contests the decision and works to restore access.
This article aggregates reporting from 8 news sources. The TL;DR is AI-generated from original reporting. Race to AGI's analysis provides editorial context on implications for AGI development.
This is the first time a major government has effectively pulled the plug on a state‑of‑the‑art frontier model after public launch, and it crystallizes a new risk category for the leading labs: geopolitical and regulatory shutdown risk. Fable 5 was Anthropic’s first Mythos‑class model released for general use, benchmarked at or near the top of public leaderboards, and was explicitly framed as safer than the full Mythos 5 system. Yet a verbal report of a narrow jailbreak and an opaque export‑control directive were enough to force a global takedown within hours.([washingtonpost.com](https://www.washingtonpost.com/technology/2026/06/13/anthropic-shuts-down-newest-ai-model-after-us-bans-foreign-use/))
For the race to AGI, this is a shot across the bow. If any government can unilaterally force a lab to withdraw a frontier model worldwide, deployment strategies and revenue forecasts for every top lab—OpenAI, Anthropic, Google DeepMind, xAI, Meta—now carry a new kind of political risk premium. It will likely accelerate lobbying for clearer pre‑release review processes and push labs to build more formal safety casework that can withstand hostile or politicized scrutiny. At the same time, it could slow or fragment global access to the most capable systems, as firms consider US‑only or nationality‑gated releases.
Competitively, the order may temporarily handicap Anthropic just as Fable 5 was differentiating it on software engineering and research workflows, while boosting the narrative that US regulators are willing to single out particular labs. That, in turn, could shape where capital, talent and even data centers flow over the next couple of years.